Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes

Diabetes

Volumn 60, Issue 4, 2011, Pages 1122-1133

  Ibrahim, Ahmed S ^a,b   El Remessy, Azza B ^a,c,d   Matragoon, Suraporn ^c,d   Zhang, Wenbo ^a   Patel, Yogin ^a   Khan, Sohail ^a   Al Gayyar, Mohammed M ^b,c,d   El Shishtawy, Mamdouh M ^b   Liou, Gregory I ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b MANSOURA UNIVERSITY   (Egypt)

^c UNIVERSITY OF GEORGIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOSYLATED ALBUMIN; IMMUNOGLOBULIN G; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; PROTEIN C JUN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; INFLAMMATION; MALE; MICROGLIA; MUELLER CELL; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; VISUAL IMPAIRMENT; WESTERN BLOTTING;

ANIMALS; CALCIUM-BINDING PROTEINS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICROGLIA; RATS; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERUM ALBUMIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79953188707     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-1160     Document Type: Article

References (50)

1. Schalkwijk CG, Poland DC, van Dijk W, et al. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia 1999;42:351-357 (Pubitemid 29111443)
2. Sjølie AK, Stephenson J, Aldington S, et al. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. Ophthalmology 1997;104:252-260
3. Krady JK, Basu A, Allen CM, et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 2005;54:1559-1565 (Pubitemid 40586690)
4. Negre-Salvayre A, Salvayre R, Augé N, Pamplona R, Portero-Otín M. Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal 2009;11:3071-3109
5. Sabbatini M, Sansone G, Uccello F, Giliberti A, Conte G, Andreucci VE. Early glycosylation products induce glomerular hyperfiltration in normal rats. Kidney Int 1992;42:875-881
6. Naitoh T, Kitahara M, Tsuruzoe N. Tumor necrosis factor-alpha is induced through phorbol ester - and glycated human albumin-dependent pathway in THP-1 cells. Cell Signal 2001;13:331-334 (Pubitemid 32448950)
7. Amore A, Cirina P, Mitola S, et al. Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. Kidney Int 1997;51:27-35 (Pubitemid 27064518)
8. Cohen MP, Shea E, Shearman CW. ERK mediates effects of glycated albumin in mesangial cells. Biochem Biophys Res Commun 2001;283:641-643 (Pubitemid 32917937)
9. Brandt R, Krantz S. Glycated albumin (Amadori product) induces activation of MAP kinases in monocyte-like MonoMac 6 cells. Biochim Biophys Acta 2006;1760;1749-1753 (Pubitemid 44667273)
10. Higai K, Shimamura A, Matsumoto K. Amadori-modified glycated albumin predominantly induces E-selectin expression on human umbilical vein endothelial cells through NADPH oxidase activation. Clin Chim Acta 2006;367:137-143
11. Chen S, Cohen MP, Ziyadeh FN. Amadori-glycated albumin in diabetic nephropathy: pathophysiologic connections. Kidney Int Suppl. 2000;77:S40-S44
12. Rodríguez-Mañas L, Angulo J, Vallejo S, et al. Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature. Diabetologia 2003;46:556-566 (Pubitemid 36577801)
13. Pu LJ, Lu L, Shen WF, et al. Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients. Circ J 2007;71:1067-1073 (Pubitemid 46998021)
14. Schalkwijk CG, Ligtvoet N, Twaalfhoven H, et al. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes 1999;48:2446-2453 (Pubitemid 30395438)
15. Tang J, Zhu XW, Lust WD, Kern TS. Retina accumulates more glucose than does the embryologically similar cerebral cortex in diabetic rats. Diabetologia 2000;43:1417-1423
16. Clements RS Jr, Robison WG Jr, Cohen MP. Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice. J Diabetes Complications 1998;12:28-33 (Pubitemid 28028759)
17. Cohen MP, Hud E, Wu VY, Shearman CW. Amelioration of diabetes-associated abnormalities in the vitreous fluid by an inhibitor of albumin glycation. Invest Ophthalmol Vis Sci 2008;49:5089-5093
18. El-Remessy AB, Khalil IE, Matragoon S, et al. Neuroprotective effect of (-) Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite. Am J Pathol 2003;163:1997-2008 (Pubitemid 37310030)
19. Shen WY, Garrett KL, Wang CG, et al. Preclinical evaluation of a phosphorothioate oligonucleotide in the retina of rhesus monkey. Lab Invest 2002;82:167-182 (Pubitemid 34160454)
20. El-Remessy AB, Tang Y, Zhu G, et al. Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation. Mol Vis 2008;14:2190-2203
21. Miele C, Riboulet A, Maitan MA, et al. Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism. J Biol Chem 2003;278:47376-47387 (Pubitemid 37523177)
22. Cohen MP, Wu VY, Cohen JA. Glycated albumin stimulates fibronectin and collagen IV production by glomerular endothelial cells under normoglycemic conditions. Biochem Biophys Res Commun 1997;239:91-94 (Pubitemid 27480321)
23. Cohen M. Diabetes and Protein Glycation. Clinical and Pathophysiologic Relevance. Philadelphia, PA, JC Press, 1996
24. Yang LP, Sun HL, Wu LM, et al. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Invest Ophthalmol Vis Sci 2009;50:2319-2327
25. Nevado J, Peiró C, Vallejo S, et al. Amadori adducts activate nuclear factor-kappaB-related proinflammatory genes in cultured human peritoneal mesothelial cells. Br J Pharmacol 2005;146:268-279 (Pubitemid 43079967)
26. Wilson KP, McCaffrey PG, Hsiao K, et al. The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chem Biol 1997;4:423-431 (Pubitemid 27288707)
27. Wang AL, Yu AC, He QH, Zhu X, Tso MO. AGEs mediated expression and secretion of TNF alpha in rat retinal microglia. Exp Eye Res 2007;84:905-913 (Pubitemid 46613882)
28. Hampson AJ, Grimaldi M, Axelrod J, Wink D. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci U S A 1998;95:8268-8273 (Pubitemid 28326102)
29. Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes 2007;56:337-345
30. Abu El-Asrar AM, Desmet S, Meersschaert A, Dralands L, Missotten L, Geboes K. Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol 2001;132:551-556 (Pubitemid 32904579)
31. Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004;18:1450-1452 (Pubitemid 39561611)
32. Kern TS, Barber AJ. Retinal ganglion cells in diabetes. J Physiol 2008;586:4401-4408
33. Aloisi F. Immune function of microglia. Glia 2001;36:165-179 (Pubitemid 33055905)
34. Wood P. Neuroinflammation: Mechanisms and Management. Totowa, NJ, Humana Press, 2003
35. Yang LP, Li Y, Zhu XA, Tso MO. Minocycline delayed photoreceptor death in rds mice through iNOS-dependent mechanism. Mol Vis 2007;13:1073-1082 (Pubitemid 47064331)
36. Bosco A, Inman DM, Steele MR, et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci 2008;49:1437-1446
37. Zeng XX, Ng YK, Ling EA. Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci 2000;17:463-471
38. Rungger-Brändle E, Dosso AA, Leuenberger PM. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 2000;41:1971-1980 (Pubitemid 30354375)
39. Zeng HY, Green WR, Tso MO. Microglial activation in human diabetic retinopathy. Arch Ophthalmol 2008;126:227-232 (Pubitemid 351240852)
40. Liu W, Xu GZ, Jiang CH, Da CD. Expression of macrophage colony-stimulating factor (M-CSF) and its receptor in streptozotocin-induced diabetic rats. Curr Eye Res 2009;34:123-133
41. Joussen AM, Doehmen S, Le ML, et al. TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol Vis 2009;15:1418-1428
42. El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol 2006;168:235-244 (Pubitemid 43062576)
43. Joussen AM, Poulaki V, Mitsiades N, et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J 2002;16:438-440
44. Lieth E, Barber AJ, Xu B, et al.; Penn State Retina Research Group. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes 1998;47:815-820
45. Yu X, Xu Z, Mi M, et al. Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocininduced Sprague-Dawley rats. Neurochem Res 2008;33:500-507 (Pubitemid 351230452)
46. Qaum T, Xu Q, Joussen AM, et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 2001;42:2408-2413 (Pubitemid 32848873)
47. Moon SE, Bhagavathula N, Varani J. Keratinocyte stimulation of matrix metalloproteinase-1 production and proliferation in fibroblasts: regulation through mitogen-activated protein kinase signalling events. Br J Cancer 2002;87:457-464 (Pubitemid 34983571)
48. Estrada Y, Dong J, Ossowski L. Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation. Pigment Cell Melanoma Res 2009;22:66-76
49. Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 2003;63:1684-1695
50. Thangapazham RL, Sharma A, Maheshwari RK. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 2006;8:E443-E449 (Pubitemid 44096605)